September 17, 2025

‘Death by a Thousand Cuts’

Rural South Texas hospitals and physicians face mounting strain as rising uninsured rates and federal funding cuts threaten access to essential health care.

KFF Health News

September 16, 2025

State’s Largest HIV Outbreak Raises Alarms

Public health experts cite syringe shortages and encampment clearings as drivers of Penobscot County’s historic HIV outbreak.

KFF Health News

September 15, 2025

FDA Approves First Intranasal Loop Diuretic

The FDA has approved Enbumyst offering a self-administered outpatient option for managing edema in patients with heart failure, liver disease, and kidney disease.

Conexiant

September 12, 2025

Organ Donation: Where Do We Draw the Line?

A case highlights challenges in brain death determination and organ donation practices.

KFF Health News

September 12, 2025

FDA Considers Ending Routine Advisory Committees on New Drugs

The FDA move to limit advisory committee involvement in drug approvals has prompted debate on the balance between efficiency and transparency.

KFF Health News

September 09, 2025

Kidney Disease Tied to Fewer Remaining Teeth, Study

Tooth count drops as dental visits lag behind in adults with chronic kidney disease.

Conexiant

September 04, 2025

'No Standard of Care' for GLP-1 Weaning

Without a defined standard of care for tapering GLP-1 medications, physicians must navigate patient management amid insurer restrictions and high discontinuation rates

KFF Health News

September 03, 2025

FDA Approves Denosumab Biosimilars

The FDA approved Bildyos and Bilprevda are providing new options comparable to Prolia and Xgeva for osteoporosis, cancer-related bone disease, and other skeletal conditions.

Conexiant

August 28, 2025

First Generic GLP-1 for Weight Loss Approved

FDA approves Teva’s generic Saxenda (liraglutide) with adult and adolescent indications and a boxed thyroid tumor warning.

Conexiant